105 related articles for article (PubMed ID: 6090175)
1. Thromboxane receptor antagonist properties of SQ 27,427 in the anesthetized guinea pig.
Greenberg R; Steinbacher TE; Harris DN; Haslanger MF
Eur J Pharmacol; 1984 Aug; 103(1-2):19-24. PubMed ID: 6090175
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 mediated bronchoconstriction in the anesthetized guinea pig.
Greenberg R; Antonaccio MJ; Steinbacher T
Eur J Pharmacol; 1982 May; 80(1):19-27. PubMed ID: 6807699
[TBL] [Abstract][Full Text] [Related]
3. Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle.
Harris DN; Greenberg R; Phillips MB; Michel IM; Goldenberg HJ; Haslanger MF; Steinbacher TE
Eur J Pharmacol; 1984 Aug; 103(1-2):9-18. PubMed ID: 6090180
[TBL] [Abstract][Full Text] [Related]
4. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analog.
Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Steinbacher TE; Ogletree ML; Hall SE
Prostaglandins; 1986 Apr; 31(4):651-67. PubMed ID: 3088677
[TBL] [Abstract][Full Text] [Related]
6. 9 alpha-homo-9,11-epoxy-5,13-prostadienoic acid analogues: specific stable agonist (SQ 26, 538) and antagonist (SQ 26, 536) of the human platelet thromboxane receptor.
Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Heikes JE; Sprague PW; Antonaccio MJ
Prostaglandins; 1981 Aug; 22(2):295-307. PubMed ID: 6270744
[TBL] [Abstract][Full Text] [Related]
7. Blockade of thromboxane responses in the airway of the cat by SQ 29,548.
Underwood DC; Kriseman T; McNamara DB; Hyman AL; Kadowitz PJ
J Appl Physiol (1985); 1987 Jun; 62(6):2193-200. PubMed ID: 2440845
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene A4-induced bronchoconstriction in the guinea pig in vivo.
Hamel R; Ford-Hutchinson AW
Prostaglandins; 1985 Dec; 30(6):935-47. PubMed ID: 3003814
[TBL] [Abstract][Full Text] [Related]
10. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
Quilley J; McGiff JC; Nasjletti A
Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
[TBL] [Abstract][Full Text] [Related]
11. Characterization of thromboxane A2/prostaglandin H2 receptors and histamine H1 receptors in cultured guinea-pig tracheal smooth-muscle cells.
Miki I; Nonaka H; Ishii A
Biochim Biophys Acta; 1992 Oct; 1137(1):107-15. PubMed ID: 1356444
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
[TBL] [Abstract][Full Text] [Related]
13. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
14. Actions of SQ 29,548 on contractile responses and arachidonic acid metabolism of intrapulmonary arteries, in vitro.
Boyd VL; Kvamme P; Harbison R; Kadowitz PJ; McNamara DB
Agents Actions; 1992 Mar; 35(3-4):280-8. PubMed ID: 1529803
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the pulmonary effects of intravenous leukotrienes and other bronchoconstrictors in anaesthetized guinea pigs.
Jones TR; Masson P
Prostaglandins; 1985 May; 29(5):799-817. PubMed ID: 3925502
[TBL] [Abstract][Full Text] [Related]
16. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
Schumacher WA; Heran CL; Ogletree ML
Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
[TBL] [Abstract][Full Text] [Related]
18. 9,11-Epoxy-9-homo-14-thiaprost-5-enoic acid derivatives: potent thromboxane A2 antagonists.
Hall SE; Han WC; Harris DN; Hedberg A; Ogletree ML
J Med Chem; 1989 May; 32(5):974-84. PubMed ID: 2523485
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
Mallarkey G; Smith GM
Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane receptor activation during bronchospasm induced by platelet-activating factor.
Schumacher WA; Steinbacher TE
J Lipid Mediat; 1991; 4(1):97-110. PubMed ID: 1832573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]